Halder Venture Appoints New Auditor, Boosts Capital, Plans Warrant Issue
Halder Venture Limited's board meeting on March 26, 2026, saw the resignation of its internal auditor and the appointment of M/s J Kumar Jain & Associates. The company also approved increasing authorized capital from ₹13.43 crore to ₹18.43 crore and plans to issue 7,93,650 warrants at ₹315 each to specified investors, including P.K. Bio Link Private Limited.
The increase in authorized capital and the proposed issuance of warrants could lead to significant fundraising and potential dilution of existing equity. The change in auditor is a routine corporate event. These actions have a medium-term impact on the company's financial structure and future capital raising capabilities.
The announcement details routine corporate actions such as auditor changes and capital restructuring, alongside a planned warrant issuance. While these are significant, they do not inherently indicate a positive or negative shift in the company's immediate financial performance or outlook.
Halder Venture Limited announced the outcome of its Board Meeting held on March 26, 2026. The board accepted the resignation of M/s Somnath Ray & Associates as Internal Auditor, effective March 18, 2026, due to preoccupation.
Subsequently, M/s J Kumar Jain & Associates, a Kolkata-based chartered accountancy firm established in 2018, was appointed as the new Internal Auditor for the Financial Year 2025-2026, commencing March 26, 2026. They are a peer-reviewed firm offering a range of auditing and consultancy services.
The board also approved an increase in the company's authorized share capital from ₹13.43 crore to ₹18.43 crore, involving the creation of an additional 50,00,000 equity shares of ₹10 each. This change to the Memorandum of Association is subject to shareholder approval via postal ballot.
Furthermore, the company plans to issue and offer up to 7,93,650 convertible warrants, each with a face value of ₹10 and an issue price of ₹315 (including a premium of ₹305). These warrants are convertible into one fully paid-up equity share each and will be offered to specified persons/entities, including P.K. Bio Link Private Limited, which is proposed to be allotted 7,93,650 warrants for ₹24,99,99,750. This preferential allotment is also subject to shareholder approval through postal ballot. A postal ballot notice will be issued to seek member consent for these proposals.
What to do with a filing like this
Halder Venture Limited filed this with the NSE as a statutory disclosure, categorised under board meeting. It is a primary document, not a recommendation, and the desk marks it medium impact: worth reading, rarely worth acting on by itself.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Halder Venture Limited. Read the original for the full detail.